0001169245-15-000001.txt : 20150312
0001169245-15-000001.hdr.sgml : 20150312
20150312103536
ACCESSION NUMBER: 0001169245-15-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150312
DATE AS OF CHANGE: 20150312
EFFECTIVENESS DATE: 20150312
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-235733
FILM NUMBER: 15694811
BUSINESS ADDRESS:
STREET 1: 4020 AERIAL CENTER PARKWAY
STREET 2: SUITE 101
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-535-8861
MAIL ADDRESS:
STREET 1: 4020 AERIAL CENTER PARKWAY
STREET 2: SUITE 101
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
D
1
primary_doc.xml
X0707
D
LIVE
0001169245
PhaseBio Pharmaceuticals Inc
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
610.981.6500
DELAWARE
Phase Biosciences Inc
DT BIOSCIENCES INC
Corporation
true
Jonathan
Mow
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Executive Officer
Director
Joel
Sussman
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Executive Officer
Ashutosh
Chilkoti
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Clay
Thorp
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Asish
K.
Xavier
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Guy
Fish
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
James
Barrett
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Justin
Klein
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Robert
Ingram
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Michael
Gutch
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Director
Biotechnology
Decline to Disclose
- 06b
false
2015-02-26
true
true
true
Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof
false
0
40000000
20000000
20000000
false
8
0
0
900000
true
false
PhaseBio Pharmaceuticals Inc
/s/ Joel Sussman
Joel Sussman
Chief Financial Officer
2015-03-10